Volume 48, Issue 1 pp. 259-265
Original Research

Investigation of diffusion kurtosis imaging for discriminating tumors from inflammatory lesions after treatment for bladder cancer

Fang Wang MD

Fang Wang MD

Department of Radiology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

Search for more papers by this author
Di Jin MD

Di Jin MD

Department of Urology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

Search for more papers by this author
Xiao-Lan Hua BS

Xiao-Lan Hua BS

Department of Radiology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

Search for more papers by this author
Zi-Zhou Zhao BS

Zi-Zhou Zhao BS

Department of Radiology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

Search for more papers by this author
Lian-Ming Wu MD, PhD

Lian-Ming Wu MD, PhD

Department of Radiology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

Search for more papers by this author
Wei-Bo Chen PhD

Wei-Bo Chen PhD

Philips Healthcare, Shanghai, China

Search for more papers by this author
Guang-Yu Wu MD

Corresponding Author

Guang-Yu Wu MD

Department of Radiology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

Address reprint requests to: G.-Y.W., Department of Radiology, Ren Ji Hospital, No. 1630, Dongfang Road, Pudong, Shanghai, 200127, China. E-mail: [email protected]Search for more papers by this author
Xiao-Xi Chen MD

Xiao-Xi Chen MD

Department of Radiology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

Search for more papers by this author
Hai-Ge Chen MD

Hai-Ge Chen MD

Department of Urology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

Search for more papers by this author
First published: 12 December 2017
Citations: 14

Fang Wang and Di Jin contributed equally to this work.

Guang-Yu Wu, Xiao-Xi Chen, and Hai-Ge Chen contributed equally to this work.

Abstract

Background

The bladder wall may thicken resulting from chronic inflammation after initial treatment (transurethral resection [TUR] or neoadjuvant chemotherapy), which may mimic the feature of recurrent or residual bladder tumors (RBT). Therefore, it is critical to discriminate RBT from benign lesions after initial treatment.

Purpose

To investigate whether diffusion kurtosis imaging (DKI) could discriminate RBT from post-therapy bladder inflammatory lesions.

Study Type

Retrospective.

Subjects

Fifty patients diagnosed with bladder cancer underwent TUR or received neoadjuvant chemotherapy.

Field Strength/Sequence

3.0T MRI/conventional T1-weighted imaging (T1WI), T2WI, and diffusion-weighted imaging (DWI) with nine b-values ranging from 0–2000 s/mm2.

Assessment

Mean diffusion coefficients (MDa, MDb, and MDc) and mean kurtosis values (MKa, MKb, and MKc) were obtained from three different measurement methods. The region of interest (ROI) was placed 1) to encompass the entire portion of the thickening bladder wall or to portions that were the most restricted, with a b-value of 2) 2000 s/mm2 or 3) 1000 s/mm2.

Statistical Tests

The independent-samples t-test was used to compare the differences between RBT and the inflammatory group. Differences in DKI parameters were analyzed by comparing the areas under the receiver-operator characteristic curves (AUCs).

Results

In patients with RBT, the MD (MDa, MDb, MDc) values were significantly lower and the MK (MKa, MKb, MKc) values were significantly higher than those in patients in the inflammatory lesions group (all P < 0.01). The AUC of MKb (0.934) was significantly larger than those of MDb, MKa, and MKc (0.793, P < 0.05; 0.694, P < 0.01; 0.719, P < 0.01, respectively).

Data Conclusion

MK obtained from DKI provided better performance than conventional DWI in distinguishing RBT from inflammatory lesions after bladder cancer treatment. MK calculated with high b-values setting provided better performance in differentiation.

Level of Evidence: 1

Technical Efficacy Stage 3

J. Magn. Reson. Imaging 2017.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.